Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers Shouji Shimoyama Mini Review 17 February 2011 Pages: 729 - 739
Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP John F. DiJosephMaureen M. DougherNitin K. Damle Original Article 03 June 2010 Pages: 741 - 749
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer Anthony W. TolcherLeonard J. ApplemanPavur R. Sundaresan Original Article Open access 03 June 2010 Pages: 751 - 764
Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure Dejan RadeskiGavin M. CullKenneth F. Ilett Original Article 08 June 2010 Pages: 765 - 768
Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract Kang Su ChoJae Young JoungKang Hyun Lee Original Article 08 June 2010 Pages: 769 - 774
Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder Joachim VandepitteBen Van CleynenbreugelPeter A. M. de Witte Original Article 09 June 2010 Pages: 775 - 781
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer Uday B. DandamudiLaurel M. AdamsLionel D. Lewis Original Article 17 June 2010 Pages: 783 - 790
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer Yasunari OkiTakashi HiroseMitsuru Adachi Original Article Open access 17 June 2010 Pages: 791 - 797
Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis Wenxing ChenYin LuBo Xu Original Article 19 June 2010 Pages: 799 - 808
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates P. A. BaxterP. A. ThompsonS. M. Blaney Original Article 19 June 2010 Pages: 809 - 812
Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells Lingmei SunYing ZhaoHongxiang Lou Original Article 19 June 2010 Pages: 813 - 821
Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells Yaprak DönmezLaila AkhmetovaUfuk Gündüz Original Article 19 June 2010 Pages: 823 - 828
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin Yutaka UedaTakahito MiyakeTadashi Kimura Original Article Open access 20 June 2010 Pages: 829 - 835
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy Gwyn BebbColum SmithAnthony Brade Original Article 20 June 2010 Pages: 837 - 845
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy Takashi SasakiHiroyuki IsayamaKazuhiko Koike Original Article 20 June 2010 Pages: 847 - 853
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors David J. AdamsWilliam R. WaudLee Roy Morgan Original Article 22 June 2010 Pages: 855 - 865
Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin Katharina Effenberger-NeidnichtRainer Schobert Original Article 26 June 2010 Pages: 867 - 874
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer Peter L. BonateCasey C. CunninghamSteve Weitman Original Article 26 June 2010 Pages: 875 - 890
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer J. P. ArnolettiA. FrolovS. M. Vickers Original Article 30 June 2010 Pages: 891 - 897
2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion Haibin XiMetin KurtogluTheodore J. Lampidis Original Article 01 July 2010 Pages: 899 - 910
Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients Hiroko MasudaNorikazu MasudaToshimasa Tsujinaka Original Article 01 July 2010 Pages: 911 - 917
Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells Germana RappaFabio AnzanelloAurelio Lorico Original Article 02 July 2010 Pages: 919 - 926
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer Srikala S. SridharChristina M. CanilMalcolm J. Moore Original Article 03 July 2010 Pages: 927 - 933
Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder Francisco Y. B. MacedoLívia T. C. MourãoRonaldo A. Ribeiro Original Article 03 July 2010 Pages: 935 - 943
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors E. Claire DeesJeffrey R. InfanteHoward Burris Original Article 07 July 2010 Pages: 945 - 954
A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors Zhao YanZhongling ZhuMeijun Liu Clinical Trial Report 30 December 2010 Pages: 955 - 961
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect Madhu B. GargStephen P. Ackland Short Communication 26 October 2010 Pages: 963 - 966
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia Grzegorz HelbigAndrzej MoskwaSławomira Kyrcz-Krzemień Letter to the Editor Open access 17 February 2011 Pages: 967 - 969
